NL-OMON33311已完成不适用
The effects of atazanavir-induced hyperbilirubinemia during human endotoxemia. - Atazanavir-induced hyperbilirubinemia during human endotoxemia.
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age >= 18 and <= 35 yrs
排除标准
- •- Use of any medication or anti-oxidant vitamin supplements
- •- History of allergic reaction to atazanavir
- •- Previous spontaneous vagal collapse
- •- History, signs or symptoms of cardiovascular disease
- •- (Family) history of myocardial infarction or stroke under the age of 65 years
- •- Cardiac conduction abnormalities on the ECG consisting of a 2nd degree atrioventricular block or a complex bundle branch block.
- •- Hypertension (defined as RR systolic > 160 or RR diastolic > 90 mmHg)
- •- Hypotension (defined as RR systolic < 100 or RR diastolic < 50)
- •- Renal impairment (defined as plasma creatinin >120 µmol/l)
- •- Liver enzyme abnormalities or positive hepatitis serology
- •- Subjects with a total bilirubin level above 15 umol/l suggesting Gilbert Syndrome.
- •- Positive HIV serology
- •- Immune deficiency
- •- Febrile illness in the week before the LPS challenge
- •- Participation in a drug trial or donation of blood 3 months prior to the LPS challenge
研究者
相似试验
已完成
不适用
The Effects of Atazanavir-induced Hyperbilirubinemia During Human EndotoxemiaInflammationMulti Organ Dysfunction SyndromeSepsisEndotoxemiaNCT00916448Radboud University Medical Center30
已完成
不适用
Impact of Hyperbilirubinemia Among HIV Patients Treated With AtazanavirHIV/AIDSNCT02532673Bristol-Myers Squibb1,200
进行中（未招募）
1 期
Measuring concentrations of the drug atazanavir along the gastrointestinal tract in human subjects after oral administration of the drug productEUCTR2017-004579-29-BEKU Leuven Drug Delivery & Disposition15
进行中（未招募）
不适用
Hyperbilirubinemia, the favourable side effect of atazanavir? Influence of atazanavir treatment on endothelial dysfunction, vascular inflammation and heme oxygenase activity in type 2 diabetes mellitus. - Hyperbilirubinemia, the favourable side effect of atazanavir?Type 2 diabetes mellitusMedDRA version: 9.1Level: LLTClassification code 10053246Term: Type II diabetes peripheral angiopathyEUCTR2008-000771-17-NLRUNMC
进行中（未招募）
1 期
Pharmacocinétique de l’atazanavir chez des patients infectés par le VIH, traités en première ligne par l’association atazanavir+ritonavir et emtricitabine+ténofovir en prise unique. - COPHAR-3EUCTR2007-003203-12-FRAgence nationale de recherches sur le sida et les hépatites virales. ANRS